QMS Medical Allied Services Limited

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange regarding the appointment of Pranav Manhar Badheka as a Non-Executive Independent Director of the company, effective September 03, 2026.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026, where the Board of Directors considered and approved the appointment of Mr. Pranav Manhar Badheka as an Additional Non-Executive, Independent Director, material related party transactions with Saarathi Healthcare Private Limited, and other matters.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has signed a five-year agreement with HEINE Optotechnik for exclusive marketing and distribution rights in India for HEINE's primary diagnostic instruments.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange about the transcript of the Earning Call for the quarter ended June 30, 2026, which includes the company's financial results and investor presentation.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has achieved a Gold certification in Cybersecurity Assessment by CyberVadis, scoring 918 out of 1000, placing it in the 'Mature' cybersecurity maturity category.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has uploaded the audio recording of its earnings call for the quarter ended June 30, 2026, on its website.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has released an investor presentation for Q1FY27, highlighting a 22% YoY revenue growth, 27% YoY EBITDA growth, and 25% YoY PAT growth. The company's integrated healthcare business model and investments have driven these results.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has released an investor presentation for Q1FY27, highlighting a strong start to the year with 22% YoY revenue growth and 25% YoY PAT growth. The company's integrated healthcare business model and investments have driven growth, with expanding distribution networks, Q-Devices portfolio, and presence across digital platforms. The Services business is emerging as a key growth engine, driven by deeper pharma partnerships and increasing adoption of Patient Support Programs.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has published a newspaper advertisement regarding the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange about the revised details of their Earnings Conference Call scheduled on Monday, August 17, 2026, to discuss the Financial Results for the quarter ended June 30, 2026.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange about the schedule of an Analyst/Institutional Investor Meeting on August 19, 2026, to be held in-person with Ashika Investment Managers. The meeting will refer to publicly available documents and no unpublished price sensitive information will be discussed.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with the company secretary and compliance officer stating that the Board of Directors have considered and approved the results.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has announced an earnings call for Q1 FY27 on August 17, 2026, to discuss its financial results for the quarter ended June 30, 2026.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited's subsidiary, Saarathi Healthcare Private Limited, has received a SOC 2 Type II Certificate for a period of 5 years, indicating robust information security and data protection standards.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has informed the Exchange regarding the closure of the trading window for directors, promoters, and designated persons from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026.

QMS Medical Allied Services Limited

QMS Medical Allied Services Limited has successfully migrated to the Mainboard of the National Stock Exchange (NSE), marking a significant milestone in the company's growth journey. The company aims to breach the Rs. 500 crore revenue mark by FY2029.